Scotia Capital Inc. Sarepta Therapeutics, Inc. Transaction History

Scotia Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $708,451 - $993,142	-10,739 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$69.38 - $86.75 $10,060 - $12,578	145 Added 1.37%	10,739 $835,000
Q1 2021 May 06, 2021	BUY	$72.25 - $168.95 $37,786 - $88,360	523 Added 5.19%	10,594 $790,000
Q4 2020 Feb 11, 2021	BUY	$125.56 - $178.74 $1.26 Million - $1.8 Million	10,071 New	10,071 $1.72 Million

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Scotia Capital Inc. with notifications on news.